捷迈邦美 ZBH
$105.59 −$1.26 (-1.18%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $105.59 0.00%
开盘$103.21
昨收$106.85
当日区间$103.21 – $106.96
成交量2.66M
市值$19.98B
市盈率（TTM）26.7
股息率0.91%
ZBH 相关新闻
匹配 Zimmer Biomet Holdings 或代码 ZBH 的头条新闻，按最新排序。
- Truist Financial Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating
- BofA Securities Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $110
- Truist Financial Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Announces Target Price $106
- A Quick Look at Today's Ratings for Zimmer Biomet Holdings(ZBH.US), With a Forecast Between $99 to $120
- J.P. Morgan Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Raises Target Price to $117 正面
- Analysts Conflicted on These Healthcare Names: ArriVent BioPharma, Inc. (AVBP), Zimmer Biomet Holdings (ZBH) and Tecan Group AG (OtherTCHBF)
- Citi Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $99
- Analysts' Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)
- Truist Financial Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $106
- BofA Securities Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Raises Target Price to $110 正面
- CCORF Upgrades Zimmer Biomet Holdings(ZBH.US) to Buy Rating, Raises Target Price to $100 正面
- Citi Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $93
- Evercore Maintains Zimmer Biomet Holdings(ZBH.US) With Buy Rating, Cuts Target Price to $110 负面
- UBS Upgrades Zimmer Biomet Holdings(ZBH.US) to Buy Rating, Raises Target Price to $115 正面
- BTIG Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating
暂无评论——快来第一个聊聊 ZBH。
登录后参与讨论。